| __timestamp | Amphastar Pharmaceuticals, Inc. | Novavax, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 79435000 |
| Thursday, January 1, 2015 | 37065000 | 162644000 |
| Friday, January 1, 2016 | 41199000 | 237939000 |
| Sunday, January 1, 2017 | 43415000 | 168435000 |
| Monday, January 1, 2018 | 57564000 | 173797000 |
| Tuesday, January 1, 2019 | 68853000 | 113842000 |
| Wednesday, January 1, 2020 | 67229000 | 747027000 |
| Friday, January 1, 2021 | 60932000 | 2534508000 |
| Saturday, January 1, 2022 | 74771000 | 1235278000 |
| Sunday, January 1, 2023 | 73741000 | 737502000 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Amphastar Pharmaceuticals, Inc. and Novavax, Inc. have demonstrated contrasting trajectories in their R&D investments. From 2014 to 2023, Amphastar's R&D expenses grew steadily, peaking at approximately $74 million in 2022, reflecting a consistent annual growth rate. In contrast, Novavax's R&D spending surged dramatically, especially during the pandemic years, reaching a zenith of $2.5 billion in 2021. This represents a staggering increase of over 3,000% from their 2014 expenditure. Such investments underscore Novavax's aggressive pursuit of vaccine development, particularly in response to global health crises. As these companies continue to innovate, their R&D strategies will likely shape the future of healthcare solutions.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Novavax, Inc.
Research and Development Investment: AstraZeneca PLC vs Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Zoetis Inc. and Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Novavax, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Grifols, S.A. and Amphastar Pharmaceuticals, Inc. Allocate Funds
Corcept Therapeutics Incorporated or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development Investment: Axsome Therapeutics, Inc. vs Novavax, Inc.
Comparing Innovation Spending: Rhythm Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc.
Research and Development Investment: Perrigo Company plc vs Novavax, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Arrowhead Pharmaceuticals, Inc. and Novavax, Inc.
Breaking Down SG&A Expenses: Amphastar Pharmaceuticals, Inc. vs Novavax, Inc.